Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2024 - 2026)
Neuroone Medical Technologies (NMTC) posted Gains from Investment Securities of $8271.0 for Q1 2026, up 103.71% on a QoQ basis from -$222740.0 in Q4 2025, and up 102.12% year-over-year from $4092.1 in Q1 2025.
Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Neuroone Medical Technologies' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $8271.0 for Q1 2026.
- Quarterly Gains from Investment Securities rose 102.12% year-over-year to $8271.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$219343.0 (changed N/A YoY) and the FY2025 annual result came in at -$784670.0, down 339.89% from the prior year.
- Gains from Investment Securities was $8271.0 for Q1 2026 at Neuroone Medical Technologies, up from -$222740.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $314751.0 in Q3 2025 and bottomed at -$390351.0 in Q1 2025.
- A 3-year average of -$166523.2 and a median of -$271182.5 in 2025 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2025 — Gains from Investment Securities surged 42.81% — and 2026, when it soared 102.12%.
- Neuroone Medical Technologies' Gains from Investment Securities stood at -$389445.0 in 2024, then surged by 42.81% to -$222740.0 in 2025, then jumped by 103.71% to $8271.0 in 2026.
- Business Quant data shows NMTC's Gains from Investment Securities at $8271.0 in Q1 2026, -$222740.0 in Q4 2025, and $314751.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Neuroone Medical Technologies | 15.70 Mn | 12.90 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,271.00 |
| Mar 31, 2026 | 8,271.00 |
| Dec 31, 2025 | -222,740.00 |
| Dec 31, 2025 | -222,740.00 |
| Sep 30, 2025 | 314,751.00 |
| Sep 30, 2025 | 314,751.00 |
| Jun 30, 2025 | -319,625.00 |
| Jun 30, 2025 | -319,625.00 |
| Mar 31, 2025 | -390,351.00 |
| Mar 31, 2025 | -390,351.00 |
| Dec 31, 2024 | -389,445.00 |
| Dec 31, 2024 | -389,445.00 |